tiprankstipranks
TELA Bio (TELA)
NASDAQ:TELA
US Market

TELA Bio (TELA) Financial Statements

168 Followers

TELA Bio Financial Overview

TELA Bio's market cap is currently $28.47M. The company's EPS TTM is $-0.17; its P/E ratio is -1.43; TELA Bio is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 80.28M$ 69.30M$ 58.45M$ 41.42M$ 29.46M
Gross Profit$ 54.34M$ 46.49M$ 40.11M$ 27.04M$ 18.81M
Operating Income$ -33.76M$ -34.12M$ -44.08M$ -39.01M$ -29.45M
EBITDA$ -33.76M$ -31.68M$ -40.63M$ -39.06M$ -29.14M
Net Income$ -38.83M$ -37.84M$ -46.66M$ -44.30M$ -33.28M
Balance Sheet
Cash & Short-Term Investments$ 50.84M$ 52.67M$ 46.73M$ 42.02M$ 43.93M
Total Assets$ 81.42M$ 87.33M$ 78.05M$ 67.86M$ 62.54M
Total Debt$ 55.65M$ 43.06M$ 42.77M$ 41.46M$ 31.49M
Net Debt$ 4.81M$ -9.61M$ -3.96M$ -563.00K$ -12.44M
Total Liabilities$ 75.11M$ 58.87M$ 59.17M$ 53.55M$ 42.45M
Stockholders' Equity$ 6.31M$ 28.46M$ 18.88M$ 14.30M$ 20.10M
Cash Flow
Free Cash Flow$ -28.67M$ -42.58M$ -41.47M$ -42.62M$ -31.06M
Operating Cash Flow$ -28.22M$ -41.59M$ -40.86M$ -40.75M$ -30.43M
Investing Cash Flow$ 846.00K$ 4.45M$ -599.00K$ -1.87M$ -627.00K
Financing Cash Flow$ 25.75M$ 43.06M$ 46.27M$ 40.85M$ 585.00K
Currency in USD

TELA Bio Earnings and Revenue History

TELA Bio Debt to Assets

TELA Bio Cash Flow

TELA Bio Forecast EPS vs Actual EPS